Savella – A New Drug Approved for the Treatment of Fibromyalgia


The Food and Drug Administration (FDA) has just approved a new drug called Savella (milnacipran HCL) for the treatment of fibromyalgia. Savella is categorized as an antidepressant, belonging to a class of drugs called serotonin and norepinephrine reuptake inhibitors (SNRI).  Savella was developed by Forest Laboratories Inc. and Cypress Bioscience Inc., and its FDA approval […]